Yakup Tanriver

Current Position

Attending Physician in Renal Medicine

Academic Education

1994 - 2001

Studies in Medicine, Charité, Universitätsmedizin Berlin

Advanced Qualifications

2020	Habilitation in Internal Medicine, University of Freiburg
2016	Board exam, Internal and Renal Medicine
2002	Doctoral degree in Medicine (Dr. med.), Charité, Universitätsmedizin Berlin

Postgraduate Positions

2016 - present	Attending Physician in Renal Medicine, Renal Division, Medical Center - University of Freiburg
2010 - present	Group Leader, Institute of Medical Microbiology and Renal Division, Medical Center - University of Freiburg
2009 - 2016	Resident, Renal Division, Medical Center - University of Freiburg
2005 - 2008	Postdoctoral Fellow, Immunoregulation Laboratory, King’s College, London, UK
2002 - 2005	Resident Department of Nephrology and Medical Intensive Care, Universitätsmedizin Charité, Berlin
2000 - 2002	MD thesis work in Transplantation Medicine at the Department of Nephrology and Medical Intensive Care, Universitätsmedizin Charité, Berlin

Link to all publications of Yakup Tanriver: PubMed

Publications on CRC 1453 funding

Arnold F, Kupferschmid L, Weissenborn P, …, Zareba P, Sagar, Rogg M, Schell C, Tanriver Y. Tissue-resident memory T cells break tolerance to renal autoantigens and orchestrate immune-mediated nephritis. Cell Mol Immunol (2024). Matuschik L, Seifert G, Lammich K, Holzner P, Tanriver Y, Fichtner-Feigl S, Walz G, Schneider J, Jänigen B. Non-antigen-specific Immunoadsorption Is a Risk Factor for Severe Postoperative Infections in ABO-Incompatible Kidney Transplant Recipients. Transpl Int (2024). Thelen B, Schipperges V, Knörlein P, Hummel JF, Arnold F, …, Arnold SJ, Börries M, Tanriver Y. Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. Front Immunol (2023). Arnold F, Huzly D, Tanriver Y, Welte T. Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune disease. BMC Infect Dis (2022). Tanriver U, Emmerich F, Hummel JF, Jänigen B, Panning M, Arnold F, Tanriver Y. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study. Clin Transplant (2022).